Original Research

Published on 31 May 2023

Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications

in Hematologic Malignancies

Claudia Bartolini
Giuseppe Roberto
Anna Girardi
Valentino Moscatelli
Andrea Spini
Alessandro Barchielli
Monica Bocchia
Alberto Fabbri
Sandra Donnini
Marina Ziche

Frontiers in Oncology

doi 10.3389/fonc.2023.1059109

1,213 views
1 citation

Brief Research Report

Published on 29 May 2023

The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes

in Hematologic Malignancies

Martin Kastnes
Kristin Roseth Aass
Siri Anshushaug Bouma
Charlotte Årseth
Muhammad Zahoor
Mariia Yurchenko
Therese Standal

Frontiers in Oncology

doi 10.3389/fonc.2023.1197542

1,947 views
1 citation

Case Report

Published on 25 May 2023

TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature

in Hematologic Malignancies

Andrew Xiao
Nahid Shahmarvand
Alexandra Nagy
Jyoti Kumar
Jessica Van Ziffle
Patrick Devine
Franklin Huang
Lhara Lezama
Peng Li
Robert S. Ohgami

Frontiers in Oncology

doi 10.3389/fonc.2023.1174606

2,238 views

Original Research

Published on 25 May 2023

Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma

in Hematologic Malignancies

Katia Mancuso
Elena Zamagni
Vincenza Solli
Liliana Gabrielli
Marta Leone
Lucia Pantani
Serena Rocchi
Ilaria Rizzello
Paola Tacchetti
Stefano Ghibellini

Frontiers in Oncology

doi 10.3389/fonc.2023.1208741

1,627 views
2 citations

Review

Published on 24 May 2023

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells

in Hematologic Malignancies

Alessandro Cellini
Federico Scarmozzino
Francesco Angotzi
Edoardo Ruggeri
Angelo Paolo Dei Tos
Livio Trentin
Marco Pizzi
Andrea Visentin

Frontiers in Oncology

doi 10.3389/fonc.2023.1203470

2,055 views
3 citations

Editorial

Published on 22 May 2023

Editorial: The management of hematologic malignancies in lower-income countries

in Hematologic Malignancies

Prasanth Ganesan
Jean El Cheikh
Alessandro Isidori
Sung-Hsin Kuo
Mustafa Saleh
Reena Nair

Frontiers in Oncology

doi 10.3389/fonc.2023.1218718

744 views
1 citation

Editorial

Published on 22 May 2023

Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients

in Hematologic Malignancies

Angelo Maiolino
Elaine Sobral Da Costa
Alberto Orfao

Frontiers in Oncology

doi 10.3389/fonc.2023.1211935

1,325 views

Mini Review

Published on 22 May 2023

Mutations, inflammation and phenotype of myeloproliferative neoplasms

in Hematologic Malignancies

Sylvie Hermouet

Frontiers in Oncology

doi 10.3389/fonc.2023.1196817

3,978 views
9 citations

Original Research

Published on 19 May 2023

Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia

in Hematologic Malignancies

Baohang Zhang
Qingguo Liu
Junfan Li
Yimin Hu
Xin Zhao
Pingping Huang
Shangzhu Li
Ying Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1193874

1,847 views
1 citation

Review

Published on 19 May 2023

Telomere biology: from disorders to hematological diseases

in Hematologic Malignancies

Kleoniki Roka
Elena E. Solomou
Antonis Kattamis

Frontiers in Oncology

doi 10.3389/fonc.2023.1167848

3,918 views
3 citations

Original Research

Published on 18 May 2023

Impact of IPSS-M implementation in real-life clinical practice

in Hematologic Malignancies

Irene Zamanillo
Maria Poza
Rosa Ayala
Inmaculada Rapado
Joaquín Martinez-Lopez
Maria Teresa Cedena

Frontiers in Oncology

doi 10.3389/fonc.2023.1199023

3,772 views
2 citations

Review

Published on 18 May 2023

The multidisciplinary approach to eosinophilia

in Hematologic Malignancies

Gunhild Nynke Thomsen
Mette Niemann Christoffersen
Hanne Merete Lindegaard
Jesper Rømhild Davidsen
Gitte Nyvang Hartmeyer
Kristian Assing
Charlotte G. Mortz
Raquel Martin-Iguacel
Michael Boe Møller
Anette Drøhse Kjeldsen

Frontiers in Oncology

doi 10.3389/fonc.2023.1193730

8,801 views
6 citations

Review

Published on 18 May 2023

Umbilical cord blood derived cellular therapy: advances in clinical development

in Hematologic Malignancies

Jiasheng Wang
Leland Metheny

Frontiers in Oncology

doi 10.3389/fonc.2023.1167266

5,052 views
9 citations

Editorial

Published on 16 May 2023

Editorial: The notch signaling pathway in lymphoid malignancies

in Hematologic Malignancies

Franco Fais
Dimitar G. Efremov

Frontiers in Oncology

doi 10.3389/fonc.2023.1216398

928 views

Original Research

Published on 16 May 2023

Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients

in Hematologic Malignancies

Paolo Lopedote
Elisabetta Xue
Julie Chotivatanapong
Emily C. Pao
Chiara Wychera
Ann E. Dahlberg
Laurel Thur
Laura Roberts
Kelsey Baker
Ted A. Gooley

Frontiers in Oncology

doi 10.3389/fonc.2023.1186503

1,915 views

Original Research

Published on 15 May 2023

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy

in Hematologic Malignancies

Zhenghua Huang
Zhen Li
Juan Wang
Ruirui Gui
Yingling Zu
Fengkuan Yu
Quande Lin
Huifang Zhao
Yanli Zhang
Baijun Fang

Frontiers in Oncology

doi 10.3389/fonc.2023.1162413

1,223 views

Navigation group

Articles

Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications

The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes

TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature

Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells

Editorial: The management of hematologic malignancies in lower-income countries

Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients

Mutations, inflammation and phenotype of myeloproliferative neoplasms

Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia

Telomere biology: from disorders to hematological diseases

Impact of IPSS-M implementation in real-life clinical practice

The multidisciplinary approach to eosinophilia

Umbilical cord blood derived cellular therapy: advances in clinical development

Editorial: The notch signaling pathway in lymphoid malignancies

Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy